Curis LifesciencesNSE:CURIS 31 Market Cap is ₹814.1 Mil as of Jul. 13, 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Curis Lifesciences ranks worse than 86.82% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Curis Lifesciences's share price for the quarter that ended in Mar. 2026 was ₹92.95. Curis Lifesciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 8.1 Mil. Therefore, Curis Lifesciences's market cap for the quarter that ended in Mar. 2026 was ₹751.4 Mil.
Curis Lifesciences's quarterly market cap
stayed the same
from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.0 Mil) but then
increased
from Mar. 2025 (₹0.0 Mil) to Mar. 2026 (₹751.4 Mil).
Curis Lifesciences's annual market cap
stayed the same
from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.0 Mil) but then
increased
from Mar. 2025 (₹0.0 Mil) to Mar. 2026 (₹751.4 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Curis Lifesciences's Enterprise Value for Today is ₹898.4 Mil.
Curis Lifesciences (NSE:CURIS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Curis Lifesciences Market Cap Related Terms
Curis Lifesciences Market Cap Historical Data
* Premium members only.
The historical data trend for Curis Lifesciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis Lifesciences Market Cap Chart
Curis Lifesciences Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Market Cap
0.00
0.00
0.00
751.41
Curis Lifesciences Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
Market Cap
0.00
0.00
0.00
751.41
NSE:CURIS vs ZTS, UTHR: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curis Lifesciences Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Curis Lifesciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Curis Lifesciences's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis Lifesciences (NSE:CURIS) has a Market Cap of ₹814.1 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Curis Lifesciences and its competitors. According to the industry distribution chart, Curis Lifesciences ranks #889 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 86.8%.
Is Curis Lifesciences' Market Cap too high?
Curis Lifesciences' current Market Cap is ₹814.1 Mil. Based on the distribution chart, Curis Lifesciences ranks #889 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curis Lifesciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curis Lifesciences ranks #889 out of 1024 companies for Market Cap. This places Curis Lifesciences in the lower half of its industry. The industry median Market Cap is 213.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.52, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Curis Lifesciences and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curis Lifesciences's current Market Cap is ₹814.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Market Cap of ₹814.1 Mil. The current Market Cap is ₹814.1 Mil. Curis Lifesciences' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Market Cap is ₹814.1 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
31GF Score
Get the complete analysis for NSE:CURIS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CURIS has been successfully added to your 